CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue that extends the duration of GH pulses by preventing enzymatic degradation
National Institute for Health and Care Excellence (NICE)
Time-to-fill data can signal whether PA paperwork is a bottleneck
The point is not that you should be able to read all the side-effects, but rather impress upon you that all medications have potential side effects, and many have lots of them
however, this program was discontinued in April 2025 following a potential drug-induced liver injury signal and earlier tolerability concerns, leaving orforglipron as the leading oral small-molecule GLP-1RA in late-stage development
Study eligibility criteria We included randomized controlled trials (RCTs), cohort studies, casecontrol studies, cross-section studies, and case series studies that evaluated the impact of L-carnitine on children